In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
We have now added a new section called the "Assay History List" to the "At A Gla...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...